BG Medicine, Inc. (BGMD) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 200 transactions totaling $18.1M, demonstrating a bullish sentiment with $14.6M in net insider flow. The most recent transaction on Mar 31, 2016 involved a transaction of 7,456 shares valued at $2.7K.
No significant insider buying has been recorded for BGMD in the recent period.
No significant insider selling has been recorded for BGMD in the recent period.
Based on recent SEC filings, insider sentiment for BGMD is bullish with an Insider Alignment Score of 90/100 and a net flow of $14.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BG Medicine, Inc. (BGMD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading BGMD stock, having executed 200 transactions in the past 90 days. The most active insider is Pe Llc Newcogen (Executive), who has made 27 transactions totaling $10.1M.
Get notified when executives and directors at BGMD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 31, 2016 | S. Adourian Aram | Executive | Payment | 7,456 | $0.36 | $2.7K | |
| Mar 31, 2016 | P. Hall Stephen | Executive | Payment | 8,986 | $0.36 | $3.2K | |
| Mar 31, 2016 | R. Sohmer Paul | Executive | Payment | 15,493 | $0.36 | $5.6K | |
| Dec 9, 2015 | Afeyan Noubar | Executive | Sale | 43,930 | $0.56 | $24.6K | |
| Dec 9, 2015 | Afeyan Noubar | Executive | Sale | 2,508 | $0.56 | $1.4K | |
| Aug 15, 2015 | S. Adourian Aram | Executive | Payment | 6,233 | $0.83 | $5.2K | |
| Aug 15, 2015 | P. Hall Stephen | Executive | Payment | 7,530 | $0.83 | $6.2K | |
| Aug 15, 2015 | R. Sohmer Paul | Executive | Payment | 13,321 | $0.83 | $11.1K | |
| Aug 15, 2015 | P. Hall Stephen | Executive | Payment | 7,505 | $0.83 | $6.2K | |
| Aug 15, 2015 | S. Adourian Aram | Executive | Payment | 6,233 | $0.83 | $5.2K | |
| Jul 27, 2015 | Technology Capital Fund Lp Applied Genomic | Executive | Exercise | 4,205 | $0.14 | $589 | |
| Jul 27, 2015 | Technology Capital Fund Lp Applied Genomic | Executive | Exercise | 53,857 | $0.14 | $7.5K | |
| Jul 27, 2015 | Technology Capital Fund Lp Applied Genomic | Executive | Sale | 530 | $2.27 | $1.2K | |
| Jul 27, 2015 | Technology Capital Fund Lp Applied Genomic | Executive | Exercise | 8,410 | $0.14 | $1.2K | |
| Jul 27, 2015 | Technology Capital Fund Lp Applied Genomic | Executive | Sale | 265 | $2.27 | $602 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 30 | $16.3M | 74.2% |
Conversion(C) | 26 | $3.4M | 15.6% |
Sale(S) | 63 | $1.8M | 8.0% |
Exercise(M) | 4 | $409.9K | 1.9% |
Payment(F) | 8 | $45.4K | 0.2% |
Exercise (Options)(X) | 52 | $19.8K | 0.1% |
Other(J) | 14 | $0 | 0.0% |
Award(A) | 3 | $0 | 0.0% |
Insiders at BG Medicine, Inc. are accumulating shares at an accelerated pace. With 17 insiders making 200 transactions totaling $16.3M in purchases versus $1.8M in sales, the net buying activity of $14.6M signals strong executive confidence. Pe Llc Newcogen (Executive) leads the buying activity with $10.1M in transactions across all time.